SOURCE: BIOLASE Technology, Inc.

BIOLASE Technology, Inc.

October 25, 2010 09:00 ET

Two New Patents Strengthen BIOLASE Intellectual Property Position in Core Waterlase® Technology and Diode Lasers

Total Issued and Pending Patents Now at 286

IRVINE, CA--(Marketwire - October 25, 2010) -  BIOLASE Technology, Inc. (NASDAQ: BLTI), the world's leading dental laser company, announced today that the United States Patent and Trademark Office issued to BIOLASE two new patents, Patent Number 7,817,687 entitled, "Electromagnetic Energy Distribution for Electromagnetically Induced Mechanical Cutting," related to the core Waterlase® YSGG™ technology and Patent Number 7,815,630, entitled, "Target-Close Electromagnetic Energy Emitting Device," related to its ezlase™ and iLase™ diode laser technology.

Dmitri Boutoussov, Chief Technology Officer, explained, "The first patent extends our Waterlase technology patent family related specifically to the unique combination of laser wavelength, pulse shape characteristics and fluid spray for the ablation of hard tissue with optimum efficiency and extends into embodiments that protect BIOLASE for future generations of hard tissue lasers. The second patent is a very broad patent that covers our current diode laser designs, disposable, bendable tips, pulse technology and a variety of other ergonomic configurations for portable diode lasers."

Federico Pignatelli, Chairman and CEO, commented, "These new patents reflect the strength of the overall BIOLASE patent portfolio and reward our commitment to maintain our R & D activities at historical levels to keep our technological leadership in both the hard tissue and diode lasers. With the two new patents, we now have 142 issued patents with 144 more pending of which approximately 70 percent focus on our core technologies."

About BIOLASE Technology, Inc.
BIOLASE Technology, Inc., the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.

For updates and information on laser and Waterlase dentistry, find BIOLASE at http://www.biolase.com, Twitter at http://twitter.com/GoWaterlase, and YouTube at http://www.youtube.com/user/Rossca08.

This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by our management. These forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," and variations of these words or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks, uncertainties and other factors which may cause the Company's actual results to differ materially from the statements contained herein, and are described in the Company's reports it files with the Securities and Exchange Commission, including its annual and quarterly reports. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and we undertake no obligation to update such statements.

Contact Information

  • For further information, please contact:
    Jill Bertotti
    Allen & Caron
    +1-949-474-4300